All co-authors were the first registered cardiovascular specialist assistants (RCSAs) whose credentials were “grandfathered” in 2010 to undergo training to become certified cardiovascular medical simulation trainers (CTAEs).
All co-authors were the first registered cardiovascular specialist assistants (RCSAs) whose credentials were “grandfathered” in 2010 to undergo training to become certified cardiovascular medical simulation trainers (CTAEs).
The Parkview Heart Institute recently became the first in Indiana to implant Boston Scientific’s S-ICD System for the prevention of life-threatening ventricular arrhythmias.
The Parkview Heart Institute recently became the first in Indiana to implant Boston Scientific’s S-ICD System for the prevention of life-threatening ventricular arrhythmias.
The authors present a case demonstrating the procedural supplies, techniques, and methods to facilitate a focal RF ablation procedure while utilizing the Achieve mapping catheter.
The authors present a case demonstrating the procedural supplies, techniques, and methods to facilitate a focal RF ablation procedure while utilizing the Achieve mapping catheter.
In this interview, EPLD speaks with Naser Partovi, Founder and CEO of Sanitas Inc., a privately held San Diego company that develops web and mobile software to help people manage their health.
In this interview, EPLD speaks with Naser Partovi, Founder and CEO of Sanitas Inc., a privately held San Diego company that develops web and mobile software to help people manage their health.
The Ortenzio Heart Center at Holy Spirit Hospital opened in November 2003. The EP lab performs an average of 30 ablations and 40-50 implants per month.
The Ortenzio Heart Center at Holy Spirit Hospital opened in November 2003. The EP lab performs an average of 30 ablations and 40-50 implants per month.
In this interview, EP Lab Digest speaks with Nancy Lurker, CEO of PDI, Inc. about CardioPredict™, a molecular diagnostic test developed by Transgenomic, Inc.
In this interview, EP Lab Digest speaks with Nancy Lurker, CEO of PDI, Inc. about CardioPredict™, a molecular diagnostic test developed by Transgenomic, Inc.
In this article, Dr. Christian Ruff discusses the North American Thrombosis Forum’s Atrial Fibrillation Action Initiative, created to identify multidisciplinary best practices for stroke prevention in atrial fibrillation.
In this article, Dr. Christian Ruff discusses the North American Thrombosis Forum’s Atrial Fibrillation Action Initiative, created to identify multidisciplinary best practices for stroke prevention in atrial fibrillation.
This is critical data that should not be ignored. Patients with AF should not ignore the relationship between operator experience and quality outcomes, and neither should those involved in hospital credentialing.
This is critical data that should not be ignored. Patients with AF should not ignore the relationship between operator experience and quality outcomes, and neither should those involved in hospital credentialing.